Company Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
0.793 USD +4.26% Intraday chart for Bionano Genomics, Inc. -7.31% -58.04%

Business Summary

Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Number of employees: 344

Sales per Business

USD in Million2022Weight2023Weight Delta
Consumables
30.9 %
7 24.2 % 11 30.9 % +65.76%
Instruments
27.7 %
9 30.8 % 10 27.7 % +16.72%
Services and Other
26.0 %
7 26.5 % 9 26.0 % +27.27%
Software
15.4 %
5 18.4 % 6 15.4 % +8.66%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
44.0 %
12 42.0 % 16 44.0 % +36.09%
EMEA
35.9 %
9 32.2 % 13 35.9 % +44.68%
China
10.0 %
1 2.5 % 4 10.0 % +418.01%
Americas
5.9 %
2 7.9 % 2 5.9 % -2.57%
Asia Pacific
4.2 %
4 15.4 % 2 4.2 % -64.48%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 11-01-11
Director of Finance/CFO 51 23-09-10
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 51 20-08-30
Chief Operating Officer 50 14-09-30
Sales & Marketing - -
General Counsel - 22-12-31
Human Resources Officer - 22-02-13
Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 64 18-06-30
Chairman 82 10-05-10
Director/Board Member 75 11-09-30
Chief Executive Officer 56 11-01-11
Director/Board Member 56 19-06-05
Director/Board Member 47 20-05-03
Director/Board Member - 22-02-16
Director/Board Member 62 20-05-03
Director/Board Member - 21-12-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 52,288,682 52,028,268 ( 99.50 %) 0 99.50 %

Shareholders

NameEquities%Valuation
Vanguard Global Advisers LLC
3.462 %
1,893,645 3.462 % 2 M $
GMT Capital Corp.
0.9695 %
530,254 0.9695 % 588 582 $
Renaissance Technologies LLC
0.9402 %
514,230 0.9402 % 570 795 $
BlackRock Institutional Trust Co. NA
0.9240 %
505,360 0.9240 % 560 950 $
Two Sigma Investments LP
0.7449 %
407,409 0.7449 % 452 224 $
Geode Capital Management LLC
0.6889 %
376,802 0.6889 % 418 250 $
317,842 0.5811 % 352 805 $
Citadel Securities GP LLC
0.3697 %
202,218 0.3697 % 224 462 $
Millennium Management LLC
0.3592 %
196,434 0.3592 % 218 042 $
D.E. Shaw & Co., Inc.
0.3140 %
171,757 0.3140 % 190 650 $

Company contact information

Bionano Genomics, Inc.

9540 Towne Centre Drive Suite 100

92121, San Diego

+858 888 7600

http://www.bionanogenomics.com
address Bionano Genomics, Inc.(BNGO)
  1. Stock Market
  2. Equities
  3. BNGO Stock
  4. Company Bionano Genomics, Inc.